Judit Molnar M.D.

Judit Molnar MD PhD serves as the VP of Clinical Development and Translational Medicine at BenevolentAI since April 2024 and holds a position as Non Executive Director at One Nucleus. Previously, Judit held the role of VP & Head Early Development at tranScrip from July 2022 to April 2024, providing translational medicine expertise and overseeing various developmental activities for small biotech companies. With an extensive background including positions at e-therapeutics PLC, Galapagos, Mission Therapeutics, and GlaxoSmithKline, Judit has led clinical development programs focusing on chronic inflammatory conditions, rare diseases, and regulatory strategy. Judit’s academic credentials include a PhD in Physiology from Cornell University and an MD from Semmelweis University. Additionally, Judit has contributed to initiatives supporting women in science and participated in academic collaborations during an industry-academic partnership at Imperial College London.